Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular Stent
Technology | Stents Drug Eluting | October 01, 2018

October 1, 2018 — Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its...

Eluvia Drug-Eluting Stent Demonstrates Superior Patency in IMPERIAL Trial
News | Stents Drug Eluting | September 26, 2018

September 26, 2018 — Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018...

Three-Year Real-World Data Support In.Pact Admiral as Primary PAD Therapy
News | Drug-Eluting Balloons | September 24, 2018

September 24, 2018 — New data announced at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept...

AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018

September 4, 2018 — Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses...

Lokai Medical to Distribute NuCryo Vascular PolarCath Balloon Dilatation System in U.S.
News | Peripheral Artery Disease (PAD) | August 14, 2018

August 14, 2018 — NuCryo Vascular announced that the company has signed a commercialization agreement with Lokai...

News | Venous Therapies | August 08, 2018

August 8, 2018 — Boston Scientific Corp. announced it has signed an agreement to...

First U.S. Patients Treated With Second-Generation Pantheris Atherectomy Device
News | Atherectomy Devices | July 18, 2018

July 18, 2018 — Avinger Inc. announced in June that several physicians have successfully treated over 40 patients...

IVUS Demonstrates Greater Visualization of Dissections in iDissection Classification Study
News | Intra-Vascular Ultrasound (IVUS) | July 12, 2018

July 12, 2018 — Intact Vascular Inc. announced the publication of the iDissection Classification trial results in...

PQ Bypass Effective in Treating Extremely Long SFA Lesions at 12 Months
News | Peripheral Artery Disease (PAD) | July 02, 2018

July 2, 2018 — The PQ Bypass Detour System showed promising 12-month durability for patients with extremely long...

FDA Approves 200, 250 Millimeter In.Pact Admiral Drug Coated Balloons
Technology | Drug-Eluting Balloons | June 15, 2018

June 15, 2018 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm...

News | Drug-Eluting Balloons | May 29, 2018

May 29, 2018 – M.A. MedAlliance SA has raised $37 million to help develop and commercialize the first sirolimus...

Avinger Receives FDA Clearance of Next-Generation Pantheris Device
Technology | Atherectomy Devices | May 24, 2018

May 24, 2018 — Avinger Inc. announced that the company received 510(k) clearance from the U.S. Food & Drug...

SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection
News | Peripheral Artery Disease (PAD) | May 15, 2018

May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to...

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease
News | Peripheral Artery Disease (PAD) | May 14, 2018

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the...

The Medtronic In.Pact Admiral Paclitaxel-coated (DCB) Percutaneous Transluminal Angioplasty Balloon Catheter is now indicated for lesions up to 360 mm in length.
Technology | Drug-Eluting Balloons | May 03, 2018

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for the Medtronic In.Pact ...

Overlay Init